SVN-002

N/A

Report date: 2025/06/11 11:22:53

Base Information

Drug NameSVN-002
Drug Alias Namecancer antibody therapeutic (Eloxx Pharmaceuticals)FB-002SVN-002
ClassificationBiologics > Protein drugs > Immunoglobulin > AntibodyBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionAngiogenesis inhibitors
TargetsUpdating
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesFabrus Inc
China Registration ClassN/A

Develop Information

Active CompaniesEloxx Pharmaceuticals Inc
Inactive CompaniesFabrus Inc
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A